Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Differential expression of unconventional myosins in apoptotic and regenerating chick hair cells confirms two regeneration mechanisms.

The Journal of comparative neurology | 2006

Hair cells of the inner ear are damaged by intense noise, aging, and aminoglycoside antibiotics. Gentamicin causes oxidative damage to hair cells, inducing apoptosis. In mammals, hair cell loss results in a permanent deficit in hearing and balance. In contrast, avians can regenerate lost hair cells to restore auditory and vestibular function. This study examined the changes of myosin VI and myosin VIIa, two unconventional myosins that are critical for normal hair cell formation and function, during hair cell death and regeneration. During the late stages of apoptosis, damaged hair cells are ejected from the sensory epithelium. There was a 4-5-fold increase in the labeling intensity of both myosins and a redistribution of myosin VI into the stereocilia bundle, concurrent with ejection. Two separate mechanisms were observed during hair cell regeneration. Proliferating supporting cells began DNA synthesis 60 hours after gentamicin treatment and peaked at 72 hours postgentamicin treatment. Some of these mitotically produced cells began to differentiate into hair cells at 108 hours after gentamicin (36 hours after bromodeoxyuridine (BrdU) administration), as demonstrated by the colabeling of myosin VI and BrdU. Myosin VIIa was not expressed in the new hair cells until 120 hours after gentamicin. Moreover, a population of supporting cells expressed myosin VI at 78 hours after gentamicin treatment and myosin VIIa at 90 hours. These cells did not label for BrdU and differentiated far too early to be of mitotic origin, suggesting they arose by direct transdifferentiation of supporting cells into hair cells.

Pubmed ID: 17048225 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

None found

Associated grants

  • Agency: NEI NIH HHS, United States
    Id: F32 EY014790-02
  • Agency: NIDCD NIH HHS, United States
    Id: R01 DC001689
  • Agency: NIDCD NIH HHS, United States
    Id: DC01689
  • Agency: NIDCD NIH HHS, United States
    Id: R01 DC001689-13
  • Agency: NEI NIH HHS, United States
    Id: F32 EY014790-03
  • Agency: NEI NIH HHS, United States
    Id: EY14790
  • Agency: NIDCD NIH HHS, United States
    Id: R01 DC001689-11A1
  • Agency: NIDCD NIH HHS, United States
    Id: R01 DC001689-14
  • Agency: NEI NIH HHS, United States
    Id: F32 EY014790
  • Agency: NIDCD NIH HHS, United States
    Id: R01 DC001689-15
  • Agency: NIDCD NIH HHS, United States
    Id: R01 DC001689-12
  • Agency: NEI NIH HHS, United States
    Id: F32 EY014790-01

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


myosin VI (antibody)

RRID:AB_2314836

This unknown targets

View all literature mentions

BrdU (antibody)

RRID:AB_400326

This monoclonal targets BrdU

View all literature mentions

Anti-βIII Tubulin mAb (antibody)

RRID:AB_430874

This monoclonal targets βIII Tubulin

View all literature mentions